Smeitinib Hydrosulfate Capsule
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Smeitinib Hydrosulfate Capsule, covering 2024-10-01 to 2024-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study on the Treatment of Type I Neurofibromatosis With Smeitinib Hydrosulfate Capsule [Phase 2]